Skip to main content
Top
Published in: Current Neurology and Neuroscience Reports 2/2016

01-02-2016 | Infection (J Halperin, Section Editor)

Developments in Varicella Zoster Virus Vasculopathy

Authors: Maria A. Nagel, Don Gilden

Published in: Current Neurology and Neuroscience Reports | Issue 2/2016

Login to get access

Abstract

Varicella zoster virus (VZV) is a highly neurotropic human herpesvirus. Primary infection usually causes varicella (chicken pox), after which virus becomes latent in ganglionic neurons along the entire neuraxis. VZV reactivation results in zoster (shingles) which is frequently complicated by chronic pain (postherpetic neuralgia). VZV reactivation also causes meningoencephalitis, myelitis, ocular disorders, and vasculopathy, all of which can occur in the absence of rash. This review focuses on the association of VZV and stroke, and on the widening spectrum of disorders produced by VZV vasculopathy in immunocompetent and immunocompromised individuals, including recipients of varicella vaccine. Aside from ischemic stroke, VZV infection of cerebral arteries may lead to development of intracerebral aneurysms, with or without hemorrhage. Moreover, recent clinical-virological case reports and retrospective pathological-virological analyses of temporal arteries positive or negative for giant cell arteritis (GCA) indicate that extracranial VZV vasculopathy triggers the immunopathology of GCA. While many patients with GCA improve after corticosteroid treatment, prolonged corticosteroid use may potentiate VZV infection, leading to fatal vasculopathy in the brain and other organs.
Literature
1.•
go back to reference Baudouin E, Lantuejoul P. Les troublecas moteurs dans le zona. Gazette des Hopitaux. 1919. The first description of stroke associated with VZV. Baudouin E, Lantuejoul P. Les troublecas moteurs dans le zona. Gazette des Hopitaux. 1919. The first description of stroke associated with VZV.
2.•
go back to reference Cheng-Ching E, Jones S, Hui FK, et al. High-resolution MRI vessel wall imaging in varicella zoster virus vasculopathy. J Neurol Sci. 2015;351:168–73. A study demonstrating decreased vessel wall thickening and decreased enhancement after antiviral treatment of VZV vasculopathy.CrossRefPubMed Cheng-Ching E, Jones S, Hui FK, et al. High-resolution MRI vessel wall imaging in varicella zoster virus vasculopathy. J Neurol Sci. 2015;351:168–73. A study demonstrating decreased vessel wall thickening and decreased enhancement after antiviral treatment of VZV vasculopathy.CrossRefPubMed
3.
go back to reference Nagel MA, Cohrs RJ, Mahalingam R, et al. The varicella zoster virus vasculopathies: clinical, CSF, imaging and virological features. Neurology. 2008;70:853–60.PubMedCentralCrossRefPubMed Nagel MA, Cohrs RJ, Mahalingam R, et al. The varicella zoster virus vasculopathies: clinical, CSF, imaging and virological features. Neurology. 2008;70:853–60.PubMedCentralCrossRefPubMed
4.
go back to reference Nagel MA, Forghani B, Mahalingam R, et al. The value of detecting anti-VZV IgG antibody in CSF to diagnose VZV vasculopathy. Neurology. 2007;68:1069–73.CrossRefPubMed Nagel MA, Forghani B, Mahalingam R, et al. The value of detecting anti-VZV IgG antibody in CSF to diagnose VZV vasculopathy. Neurology. 2007;68:1069–73.CrossRefPubMed
5.
go back to reference Gilden D, Nagel MA, Cohrs RJ, Mahalingam R. The variegate neurological manifestations of varicella zoster virus infection. Curr Neurol Neurosci Rep. 2013;13:374.PubMedCentralCrossRefPubMed Gilden D, Nagel MA, Cohrs RJ, Mahalingam R. The variegate neurological manifestations of varicella zoster virus infection. Curr Neurol Neurosci Rep. 2013;13:374.PubMedCentralCrossRefPubMed
6.
go back to reference Lin HC, Cw C, Ho JD. Herpes zoster ophthalmicus and the risk of stroke: a population-based follow-up study. Neurology. 2010;74:792–7.CrossRefPubMed Lin HC, Cw C, Ho JD. Herpes zoster ophthalmicus and the risk of stroke: a population-based follow-up study. Neurology. 2010;74:792–7.CrossRefPubMed
7.
go back to reference Kang JH, Ho JD, Chen YH, et al. Increased risk of stroke after a herpes zoster attack: a population-based follow-up study. Stroke. 2009;40:3443–8.CrossRefPubMed Kang JH, Ho JD, Chen YH, et al. Increased risk of stroke after a herpes zoster attack: a population-based follow-up study. Stroke. 2009;40:3443–8.CrossRefPubMed
8.
go back to reference Sreenivasan N, Basit S, Wohlfahrt J, et al. The short- and long-term risk of stroke after herpes zoster—a nationwide population-based cohort study. PLoS One. 2013;8:e69156.PubMedCentralCrossRefPubMed Sreenivasan N, Basit S, Wohlfahrt J, et al. The short- and long-term risk of stroke after herpes zoster—a nationwide population-based cohort study. PLoS One. 2013;8:e69156.PubMedCentralCrossRefPubMed
9.
go back to reference Breuer J, Pacou M, Gauthier A, Brown MM. Herpes zoster as a risk factor for stroke and TIA: a retrospective cohort study in the UK. Neurology. 2014;82:206–12.PubMedCentralCrossRefPubMed Breuer J, Pacou M, Gauthier A, Brown MM. Herpes zoster as a risk factor for stroke and TIA: a retrospective cohort study in the UK. Neurology. 2014;82:206–12.PubMedCentralCrossRefPubMed
10.
go back to reference Langan SM, Minassian C, Smeeth L, Thomas SL. Risk of stroke following herpes zoster: a self-controlled case-series study. Clin Infect Dis. 2014;58:1497–503.PubMedCentralCrossRefPubMed Langan SM, Minassian C, Smeeth L, Thomas SL. Risk of stroke following herpes zoster: a self-controlled case-series study. Clin Infect Dis. 2014;58:1497–503.PubMedCentralCrossRefPubMed
11.
12.
go back to reference Nagel MA, Traktinskiy I, Stenmark KR, Frid MG, Choe A, Gilden D. Varicella zoster virus vasculopathy: immune characteristics of virus-infected arteries. Neurology. 2013;80:62–8.PubMedCentralCrossRefPubMed Nagel MA, Traktinskiy I, Stenmark KR, Frid MG, Choe A, Gilden D. Varicella zoster virus vasculopathy: immune characteristics of virus-infected arteries. Neurology. 2013;80:62–8.PubMedCentralCrossRefPubMed
13.
go back to reference Gursoy G, Aktin E, Bahar S, et al. Post-herpetic aneurysm in the intrapetrosal portion of the internal carotid artery. Neuroradiology. 1980;9:279–82. Gursoy G, Aktin E, Bahar S, et al. Post-herpetic aneurysm in the intrapetrosal portion of the internal carotid artery. Neuroradiology. 1980;9:279–82.
14.
go back to reference O’Donohue JM, Enzmann DR. Mycotic aneurysm in angiitis associated with herpes zoster ophthalmicus. AJNR Am J Neuroradiol. 1987;8:615–9.PubMed O’Donohue JM, Enzmann DR. Mycotic aneurysm in angiitis associated with herpes zoster ophthalmicus. AJNR Am J Neuroradiol. 1987;8:615–9.PubMed
15.
go back to reference Fukumoto S, Kinjo M, Hokamura K, et al. Subarachnoid hemorrhage and granulomatous angiitis of the basilar artery: demonstration of the varicella-zoster virus in the basilar artery lesions. Stroke. 1986;17:1024–8.CrossRefPubMed Fukumoto S, Kinjo M, Hokamura K, et al. Subarachnoid hemorrhage and granulomatous angiitis of the basilar artery: demonstration of the varicella-zoster virus in the basilar artery lesions. Stroke. 1986;17:1024–8.CrossRefPubMed
16.
go back to reference Fulmer BB, Dillard SC, Musulman EM, et al. Two cases of cerebral aneurysms in HIV+ children. Pediatr Neurosurg. 1998;28:31–4.CrossRefPubMed Fulmer BB, Dillard SC, Musulman EM, et al. Two cases of cerebral aneurysms in HIV+ children. Pediatr Neurosurg. 1998;28:31–4.CrossRefPubMed
17.
go back to reference Saraya T, Shimura C, Wada H, et al. Evidence for vascular spread of varicella zoster-associated vasculopathy. Ann Intern Med. 2006;144:535–7.CrossRefPubMed Saraya T, Shimura C, Wada H, et al. Evidence for vascular spread of varicella zoster-associated vasculopathy. Ann Intern Med. 2006;144:535–7.CrossRefPubMed
18.
go back to reference de Broucker T, Verollet D, Schoindre Y, et al. Cerebral vasculitis with aneurysms caused by varicella-zoster virus infection during AIDS: a new clinicoangiographical syndrome. Rev Neurol (Paris). 2008;164:61–71.CrossRef de Broucker T, Verollet D, Schoindre Y, et al. Cerebral vasculitis with aneurysms caused by varicella-zoster virus infection during AIDS: a new clinicoangiographical syndrome. Rev Neurol (Paris). 2008;164:61–71.CrossRef
19.
go back to reference Yasuda C, Okada K, Ohnari N, et al. Cerebral infarction and intracranial aneurysm related to the reactivation of varicella zoster virus in a Japanese acquired immunodeficiency syndrome (AIDS) patient. Rinsho Shinkeigaku. 2013;53:701–5.CrossRefPubMed Yasuda C, Okada K, Ohnari N, et al. Cerebral infarction and intracranial aneurysm related to the reactivation of varicella zoster virus in a Japanese acquired immunodeficiency syndrome (AIDS) patient. Rinsho Shinkeigaku. 2013;53:701–5.CrossRefPubMed
20.
go back to reference Bhayani N, Ranade P, Clark NM, et al. Varicella-zoster virus and cerebral aneurysm: case report and review of the literature. Clin Infect Dis. 2008;47:e1–3.CrossRefPubMed Bhayani N, Ranade P, Clark NM, et al. Varicella-zoster virus and cerebral aneurysm: case report and review of the literature. Clin Infect Dis. 2008;47:e1–3.CrossRefPubMed
21.
go back to reference Kawatani M, Nakai A, Okuno T, et al. A case of intracranial saccular aneurysm after primary varicella zoster virus infection. Brain Dev. 2012;34:80–2.CrossRefPubMed Kawatani M, Nakai A, Okuno T, et al. A case of intracranial saccular aneurysm after primary varicella zoster virus infection. Brain Dev. 2012;34:80–2.CrossRefPubMed
22.•
go back to reference Liberman AL, Nagel MA, Hurley MC, et al. Rapid development of nine cerebral aneurysms in varicella zoster virus vasculopathy. Neurology. 2014;82:2139–41. A study of aneurysms associated with VZV vasculopathy and improvement with antiviral therapy.PubMedCentralCrossRefPubMed Liberman AL, Nagel MA, Hurley MC, et al. Rapid development of nine cerebral aneurysms in varicella zoster virus vasculopathy. Neurology. 2014;82:2139–41. A study of aneurysms associated with VZV vasculopathy and improvement with antiviral therapy.PubMedCentralCrossRefPubMed
23.
go back to reference Wise RP, Salive ME, Braun MM, et al. Postlicensure safety surveillance for varicella vaccine. JAMA. 2000;284:1271–9.CrossRefPubMed Wise RP, Salive ME, Braun MM, et al. Postlicensure safety surveillance for varicella vaccine. JAMA. 2000;284:1271–9.CrossRefPubMed
24.
go back to reference Levin MJ, DeBiasi RL, Bostik V, et al. Herpes zoster with skin lesions and meningitis caused by 2 different genotypes of the Oka varicella-zoster virus vaccine. J Infect Dis. 2008;198:1444–7.CrossRefPubMed Levin MJ, DeBiasi RL, Bostik V, et al. Herpes zoster with skin lesions and meningitis caused by 2 different genotypes of the Oka varicella-zoster virus vaccine. J Infect Dis. 2008;198:1444–7.CrossRefPubMed
25.
go back to reference Iyer S, Mittal MK, Hodinka RL. Herpes zoster and meningitis resulting from reactivation of varicella vaccine virus in an immunocompetent child. Ann Emerg Med. 2009;53:792–5.CrossRefPubMed Iyer S, Mittal MK, Hodinka RL. Herpes zoster and meningitis resulting from reactivation of varicella vaccine virus in an immunocompetent child. Ann Emerg Med. 2009;53:792–5.CrossRefPubMed
26.
go back to reference Han JY, Hanson DC, Way SS. Herpes zoster and meningitis due to reactivation of varicella vaccine virus in an immunocompetent child. Pediatr Infect Dis J. 2011;30:266–8.CrossRefPubMed Han JY, Hanson DC, Way SS. Herpes zoster and meningitis due to reactivation of varicella vaccine virus in an immunocompetent child. Pediatr Infect Dis J. 2011;30:266–8.CrossRefPubMed
27.
go back to reference Wirrell E, Hill MD, Jadavji T, et al. Stroke after varicella vaccination. J Pediatr. 2004;145:845–7.CrossRefPubMed Wirrell E, Hill MD, Jadavji T, et al. Stroke after varicella vaccination. J Pediatr. 2004;145:845–7.CrossRefPubMed
28.
go back to reference Sabry A, Hauk PJ, Jing H, et al. Vaccine strain varicella-zoster virus-induced central nervous system vasculopathy as the presenting feature of DOCK8 deficiency. J Allergy Clin Immunol. 2014;133:1225–7.PubMedCentralCrossRefPubMed Sabry A, Hauk PJ, Jing H, et al. Vaccine strain varicella-zoster virus-induced central nervous system vasculopathy as the presenting feature of DOCK8 deficiency. J Allergy Clin Immunol. 2014;133:1225–7.PubMedCentralCrossRefPubMed
29.
go back to reference Al-Abdulla NA, Rismondo V, Minkowski JS, et al. Herpes zoster vasculitis presenting as giant cell arteritis with bilateral internuclear ophthalmoplegia. Am J Ophthalmol. 2002;134:912–4.CrossRefPubMed Al-Abdulla NA, Rismondo V, Minkowski JS, et al. Herpes zoster vasculitis presenting as giant cell arteritis with bilateral internuclear ophthalmoplegia. Am J Ophthalmol. 2002;134:912–4.CrossRefPubMed
30.
go back to reference Al-Abdulla NA, Kelley JS, Green WR, et al. Herpes zoster vasculitis presenting as giant cell arteritis with choroidal infarction. Retina. 2003;23:567–9.CrossRefPubMed Al-Abdulla NA, Kelley JS, Green WR, et al. Herpes zoster vasculitis presenting as giant cell arteritis with choroidal infarction. Retina. 2003;23:567–9.CrossRefPubMed
31.
go back to reference de Castro LE, Peterson AM, Givre SJ, et al. Herpes zoster ophthalmicus: presenting as giant-cell arteritis. Clin Experiment Ophthalmol. 2005;33:636–8.CrossRefPubMed de Castro LE, Peterson AM, Givre SJ, et al. Herpes zoster ophthalmicus: presenting as giant-cell arteritis. Clin Experiment Ophthalmol. 2005;33:636–8.CrossRefPubMed
32.••
go back to reference Nagel MA, White T, Khmeleva N, et al. Analysis of varicella-zoster virus in temporal arteries biopsy-positive and -negative for giant cell arteritis. JAMA Neurol. 2015;72:1281–7. An extensive, retrospective study of temporal artery biopsies showing that most GCA-negative and GCA-positive arteries contain VZV antigen. Nagel MA, White T, Khmeleva N, et al. Analysis of varicella-zoster virus in temporal arteries biopsy-positive and -negative for giant cell arteritis. JAMA Neurol. 2015;72:1281–7. An extensive, retrospective study of temporal artery biopsies showing that most GCA-negative and GCA-positive arteries contain VZV antigen.
33.
go back to reference Salazar R, Russman AN, Nagel MA, et al. Varicella zoster virus ischemic optic neuropathy and subclinical temporal artery involvement. Arch Neurol. 2011;68:517–20.PubMedCentralCrossRefPubMed Salazar R, Russman AN, Nagel MA, et al. Varicella zoster virus ischemic optic neuropathy and subclinical temporal artery involvement. Arch Neurol. 2011;68:517–20.PubMedCentralCrossRefPubMed
34.
go back to reference Nagel MA, Khmeleva N, Boyer PJ, et al. Varicella zoster virus in the temporal artery of a patient with GCA. J Neurol Sci. 2013;335:229–30.CrossRef Nagel MA, Khmeleva N, Boyer PJ, et al. Varicella zoster virus in the temporal artery of a patient with GCA. J Neurol Sci. 2013;335:229–30.CrossRef
35.
go back to reference Mathias M, Nagel MA, Khmeleva N, et al. VZV multifocal vasculopathy with ischemic optic neuropathy, acute retinal necrosis and temporal artery infection in the absence of zoster rash. J Neurol Sci. 2013;325:180–2.PubMedCentralCrossRefPubMed Mathias M, Nagel MA, Khmeleva N, et al. VZV multifocal vasculopathy with ischemic optic neuropathy, acute retinal necrosis and temporal artery infection in the absence of zoster rash. J Neurol Sci. 2013;325:180–2.PubMedCentralCrossRefPubMed
36.
go back to reference Nagel MA, Bennett JL, Khmeleva N, et al. Multifocal VZV vasculopathy with temporal artery infection mimics giant cell arteritis. Neurology. 2013;80:2017–21.PubMedCentralCrossRefPubMed Nagel MA, Bennett JL, Khmeleva N, et al. Multifocal VZV vasculopathy with temporal artery infection mimics giant cell arteritis. Neurology. 2013;80:2017–21.PubMedCentralCrossRefPubMed
37.••
go back to reference Gilden D, White T, Khmeleva N, et al. Prevalence and distribution of VZV in temporal arteries of patients with giant cell arteritis. Neurology. 2015;84:1948–55. The first extensive, retrospective study of temporal artery biopsies showing a causal link between VZV and biopsy-positive giant cell arteritis, as evidenced by the presence of VZV antigen, VZV DNA and herpesvirus particles in the temporal artery.CrossRefPubMed Gilden D, White T, Khmeleva N, et al. Prevalence and distribution of VZV in temporal arteries of patients with giant cell arteritis. Neurology. 2015;84:1948–55. The first extensive, retrospective study of temporal artery biopsies showing a causal link between VZV and biopsy-positive giant cell arteritis, as evidenced by the presence of VZV antigen, VZV DNA and herpesvirus particles in the temporal artery.CrossRefPubMed
38.
go back to reference Chakravarty EF, Michaud K, Katz R, et al. Increased incidence of herpes zoster among patients with systemic lupus erythematosus. Lupus. 2013;22:238–44.CrossRefPubMed Chakravarty EF, Michaud K, Katz R, et al. Increased incidence of herpes zoster among patients with systemic lupus erythematosus. Lupus. 2013;22:238–44.CrossRefPubMed
39.
go back to reference Cavallasca JA, Costa CA, Mdel M, et al. Severe infections in patients with autoimmune diseases treated with cyclophosphamide. Reumatol Clin. 2015;11:221–3.CrossRefPubMed Cavallasca JA, Costa CA, Mdel M, et al. Severe infections in patients with autoimmune diseases treated with cyclophosphamide. Reumatol Clin. 2015;11:221–3.CrossRefPubMed
40.
go back to reference Pappas DA, Hooper MM, Kremer JM, et al. Herpes zoster reactivation in patients with rheumatoid arthritis: analysis of disease characteristics and disease modifying anti-rheumatic drugs. Arthritis Care Res (Hoboken). 2015. doi:10.1002/acr.22628. Pappas DA, Hooper MM, Kremer JM, et al. Herpes zoster reactivation in patients with rheumatoid arthritis: analysis of disease characteristics and disease modifying anti-rheumatic drugs. Arthritis Care Res (Hoboken). 2015. doi:10.​1002/​acr.​22628.
41.
go back to reference Tako J, Rado JP. Zoster meningoencephalitis in a steroid-treated patient. Arch Neurol. 1962;12:610–2.CrossRef Tako J, Rado JP. Zoster meningoencephalitis in a steroid-treated patient. Arch Neurol. 1962;12:610–2.CrossRef
42.
go back to reference Nagel MA, Lenggenhager D, White T, et al. Disseminated VZV infection and asymptomatic VZV vasculopathy after steroid abuse. J Clin Virol. 2015;66:72–5.CrossRefPubMed Nagel MA, Lenggenhager D, White T, et al. Disseminated VZV infection and asymptomatic VZV vasculopathy after steroid abuse. J Clin Virol. 2015;66:72–5.CrossRefPubMed
43.
go back to reference Galetta SL, Balcer LJ, Lieberman AP, et al. Refractory giant cell arteritis with spinal cord infarction. Neurology. 1997;49:1720–3.CrossRefPubMed Galetta SL, Balcer LJ, Lieberman AP, et al. Refractory giant cell arteritis with spinal cord infarction. Neurology. 1997;49:1720–3.CrossRefPubMed
Metadata
Title
Developments in Varicella Zoster Virus Vasculopathy
Authors
Maria A. Nagel
Don Gilden
Publication date
01-02-2016
Publisher
Springer US
Published in
Current Neurology and Neuroscience Reports / Issue 2/2016
Print ISSN: 1528-4042
Electronic ISSN: 1534-6293
DOI
https://doi.org/10.1007/s11910-015-0614-5

Other articles of this Issue 2/2016

Current Neurology and Neuroscience Reports 2/2016 Go to the issue

Neuro-oncology (L. E. Abrey, Section Editor)

Nitrosoureas in the Management of Malignant Gliomas

Headache (R. B. Halker, Section Editor)

Non-Invasive Neuromodulation for Headache Disorders

Neurology of Systemic Diseases (J Biller, Section Editor)

Neurocutaneous Disorders for the Practicing Neurologist: a Focused Review